10.01.2011 • News

Euticals to Acquire Archimica Group

The Italian pharma fine chemicals company Euticals will buy Archimica from TowerBrook Capital Parners for an undisclosed sum. Completion of the transaction is expected in early February.

TowerBrook acquired Archimica, a player in the pharmaceutical fine chemicals industry, in June 2006. The company has approximately 550 employees at six production sites in Italy, France, Germany, US and UK and achieved strong sales of €131 million in 2009, a 16% increase from 2008.

Euticals Group is a successful pharmaceuticals fine chemicals company with sales in 2010 of €93 million and five production sites near Milan, Italy. Euticals and Archimica said they expect the combination to be strategic, creating new opportunities to further develop business activities in the fine chemicals sector.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.